Alzheimer's drug co-developed by Eisai approved for use in Japan | The Asahi Shimbun: Breaking News, Japan News and Analysis

The health ministry approved a medication that helps slow progression of Alzheimer’s disease in the early stages, meaning the drug will become commercially available as early as the end of the year.

Related Keywords

Japan ,United States ,Haruo Naito ,Biogen Inc ,Japan Ministry Of Health ,Japan Eisai Co ,National Report ,Asahi Shimbun ,News ,